Form 4: Coliseum Capital Management Sells Shares of Universal Technical Institute Inc (UTI)

Coliseum Capital Management, along with related entities and individuals, sold 1,929,488 shares of Universal Technical Institute Inc (UTI) at a price of $32.95 per share on May 12, 2025.

Summary

• On May 12, 2025, Coliseum Capital Management, LLC, along with related entities and individuals, disposed of 1,929,488 shares of Universal Technical Institute Inc (UTI) common stock.
• The transaction was executed at a price of $32.95 per share.
• Following the transaction, Coliseum Capital Partners, L.P. holds 2,666,368 shares of Common Stock and the Separate Account holds 549,899 shares of Common Stock.
• The reporting parties include Coliseum Capital Management, LLC, Christopher Shackelton, Coliseum Capital, LLC, Coliseum Capital Partners, L.P., and Adam Gray, all of whom may be deemed directors by deputization.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. The sale of shares could be interpreted negatively, but without further context, it's just a factual reporting of a transaction.

Negatives

• Coliseum Capital Management reduced its stake in Universal Technical Institute Inc (UTI) by selling a significant number of shares.

Risks

• The sale of a large block of shares by a major shareholder like Coliseum Capital could potentially exert downward pressure on the stock price of Universal Technical Institute Inc (UTI).

Industry Context

Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency on insider transactions. This filing indicates a change in the holdings of a major shareholder, which is relevant information for investors.

Stakeholder Impact

• Shareholders may react to the news of Coliseum Capital's share sale, potentially impacting the stock price.
• The company's management will need to address any concerns arising from this transaction to maintain investor confidence.

Key Dates

Keywords

UTI, Universal Technical Institute Inc, Coliseum Capital Management, share sale, Form 4, beneficial ownership, stock transaction